- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07849010
Disposable Noninvasive Skin Closure for Promoting Postoperative Wound Healing and Preventing Surgical Skin Scarring
Disposable Noninvasive Skin Closure for Promoting Postoperative Wound Healing and Preventing Surgical Skin Scarring: A Single-Center, Prospective, Randomized Split-Scar, Self-Controlled Clinical Trial
The purpose of this study is to evaluate the efficacy and safety of a disposable noninvasive skin closure device in promoting postoperative wound healing and reducing surgical scar formation. Participants will receive the device on one half of the surgical incision, with the other half serving as a control. Wound healing and scar appearance will be assessed during follow-up visits after surgery.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Surgical wounds can heal with visible scars. Tension on the skin may affect wound healing and scar formation. This study will evaluate whether a disposable noninvasive skin closure device can improve healing and reduce scar formation after plastic surgery.
Adults undergoing plastic surgery with an incision longer than 2 cm on the cheek, neck, trunk, or limbs will be enrolled. Each participant's incision will be divided into two parts. By random assignment, the device will be applied to one part of the incision, while the other part will receive standard postoperative care without the device. This within-participant comparison allows each participant to serve as their own control.
Participants will return for assessments at 1, 3, and 6 months after surgery. Blinded plastic surgeons will assess wound healing and scar appearance using standardized scar-rating tools. The study will evaluate whether the device is safe and effective for supporting postoperative wound healing and preventing surgical scar formation.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Yimou Sun, M.D.
- Numéro de téléphone: +86 13811625471
- E-mail: sym316@126.com
Sauvegarde des contacts de l'étude
- Nom: Mengying Jin, M.D.
- Numéro de téléphone: +86 18811331677
- E-mail: 1510301328@pku.edu.cn
Lieux d'étude
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Chine, 100191
- Recrutement
- Peking University Third Hospital
-
Contact:
- Mengying Jin, M.D.
- Numéro de téléphone: +86 18811331677
- E-mail: 1510301328@pku.edu.cn
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Adults aged 20 to 50 years undergoing plastic surgery
- Surgical incision located on the cheek, neck, trunk, or limbs, excluding the hands and feet
- Surgical incision longer than 2 cm
- Willing and able to provide written informed consent
Exclusion Criteria:
- History of abnormal scar formation or keloids
- Autoimmune disease
- Surgical wound infection
- Use of any scar treatment or wound treatment other than the study device during the study period
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Tension Reduction
The disposable noninvasive skin closure device will be applied to the randomly assigned half of the surgical incision for 3 months after surgery. |
A disposable noninvasive skin closure device will be applied to the randomly assigned half of each participant's surgical incision after routine suturing. The device is designed to reduce tension across the skin surface without penetrating the skin. It will be used continuously for 3 months after surgery, while the other half of the incision will receive routine postoperative care without tension-reduction treatment. |
|
Aucune intervention: Control
The other half of the same surgical incision will receive routine postoperative care without the disposable noninvasive skin closure device. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Vancouver Scar Scale (VSS) score
Délai: 6 months after surgery
|
Blinded plastic surgeons will assess each half of the surgical incision using the VSS. Lower scores indicate a better scar outcome. |
6 months after surgery
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Modified Patient and Observer Scar Assessment Scale (mPOSAS) score
Délai: 1, 3, and 6 months after surgery
|
Blinded plastic surgeons will assess scar appearance for each half of the surgical incision using the mPOSAS. Lower scores indicate a better scar outcome. |
1, 3, and 6 months after surgery
|
|
Device-related adverse events
Délai: 1, 3, and 6 months after surgery
|
Skin redness, itching, and other adverse events related to use of the disposable noninvasive skin closure device will be recorded. |
1, 3, and 6 months after surgery
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Yimou Sun, M.D., Peking University Third Hospital
Publications et liens utiles
Publications générales
- Menkowitz B, Olivieri G, Belson O. Patient Satisfaction and Cosmetic Outcome in a Randomized, Prospective Study of Total Knee Arthroplasty Skin Closure Comparing Zip Surgical Skin Closure with Staples. Cureus. 2020 Jan 19;12(1):e6705. doi: 10.7759/cureus.6705.
- Gorsulowsky DC, Talmor G. A novel noninvasive wound closure device as the final layer in skin closure. Dermatol Surg. 2015 Aug;41(8):987-9. doi: 10.1097/DSS.0000000000000399. No abstract available.
- Tanaka Y, Miyamoto T, Naito Y, Yoshitake S, Sasahara A, Miyaji K. Randomized Study of a New Noninvasive Skin Closure Device for Use After Congenital Heart Operations. Ann Thorac Surg. 2016 Oct;102(4):1368-74. doi: 10.1016/j.athoracsur.2016.03.072. Epub 2016 Jun 1.
- Kjonniksen I, Winderen M, Bruland O, Fodstad O. Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats. Cancer Res. 1994 Apr 1;54(7):1715-9.
- Gold MH, McGuire M, Mustoe TA, Pusic A, Sachdev M, Waibel J, Murcia C; International Advisory Panel on Scar Management. Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. Dermatol Surg. 2014 Aug;40(8):825-31. doi: 10.1111/dsu.0000000000000050.
- Gold MH, Berman B, Clementoni MT, Gauglitz GG, Nahai F, Murcia C. Updated international clinical recommendations on scar management: part 1--evaluating the evidence. Dermatol Surg. 2014 Aug;40(8):817-24. doi: 10.1111/dsu.0000000000000049.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- M2024719
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
IPD will not be shared because the study involves identifiable clinical photographs and sensitive personal health information. To protect participant privacy and confidentiality, individual participant data will remain restricted to the study team.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .